Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase 3 5Phase 1 5Phase 1/2 3Phase NA 2

Status

Completed 4Active not recruiting 1

Sponsor Class

NIH 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 5

Conditions

Breast Neoplasms 60Prostatic Neoplasms 52Squamous Cell Carcinoma of Head and Neck 43Carcinoma, Non-Small-Cell Lung 39Head and Neck Neoplasms 37Lung Neoplasms 35Lymphoma 34Leukemia 22Brain Neoplasms 20Central Nervous System Neoplasms 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Glioblastoma 18Uterine Cervical Neoplasms 17Sarcoma 17Rectal Neoplasms 17Lymphoma, Follicular 16Esophageal Squamous Cell Carcinoma 16Esophageal Neoplasms 15Lymphoma, Large B-Cell, Diffuse 14Hodgkin Disease 14Burkitt Lymphoma 14Adenocarcinoma of Lung 13Oligodendroglioma 12Lymphoma, Non-Hodgkin 12Neoplasm Metastasis 11Astrocytoma 11Rhabdomyosarcoma 10Lymphoma, Large-Cell, Immunoblastic 10Neuroblastoma 9Nasopharyngeal Carcinoma 9

Interventions

Gemcitabine 28Cisplatin 26Mitomycin 18BCG Vaccine 12pembrolizumab 9Paclitaxel 8Doxorubicin 7Docetaxel 75-aminolevulinic acid hexyl ester 7apaziquone 6Carboplatin 6vinflunine 5enfortumab vedotin 5atezolizumab 5Vinblastine 5Radiotherapy 5Methotrexate 5Magnetic Resonance Spectroscopy 5Fluorouracil 5Cystectomy 5durvalumab 4Surgical Procedures, Operative 4Nivolumab 4Transurethral Resection of Bladder 3Specimen Handling 3Selenium 3Radiation 3Filgrastim 3Cystoscopy 3BCG Connaught 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Urinary Bladder Neoplasms × Radiotherapy × Clear all
NCT03775265 2026-05-04

Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
475 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00867347 2019-01-04

Radiation Therapy or Surgery in Treating Patients Receiving Chemotherapy for Bladder Cancer

Institute of Cancer Research, United Kingdom

Phase 3 Completed
45 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00002490 2013-12-18

Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer

National Cancer Institute (NCI)

Phase 3 Completed
Genitourinary

Urinary Bladder Neoplasms

NCT00024349 2013-12-18

Radiation Therapy With or Without Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer

National Cancer Institute (NCI)

Phase 3 Completed
350 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT00033436 2013-09-20

Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer

National Cancer Institute (NCI)

Phase 3 Completed
330 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡